Renoprotective effect of paricalcitol via a modulation of the TLR4-NF-κB pathway in ischemia/reperfusion-induced acute kidney injury

Biochemical and Biophysical Research Communications

Volumn 444, Issue 2, 2014, Pages 121-127

  Lee, Jae Won ^a   Kim, Sun Chul ^a   Ko, Yoon Sook ^a   Lee, Hee Young ^a   Cho, Eunjung ^a   Kim, Myung Gyu ^a   Jo, Sang Kyung ^a   Cho, Won Yong ^a   Kim, Hyoung Kyu ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Acute kidney injury; NF B; Paricalcitol; Toll like receptor 4

Indexed keywords

ACUTE KIDNEY INJURY; NF-ΚB; PARICALCITOL; TOLL-LIKE RECEPTOR 4;

ACUTE KIDNEY INJURY; ANIMALS; BLOTTING, WESTERN; CELL LINE; CHEMOKINE CCL2; CHEMOKINES; CREATINE; ERGOCALCIFEROLS; HUMANS; I-KAPPA B KINASE; INFLAMMATION; INTERLEUKIN-6; KIDNEY; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

EID: 84894586555     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.005     Document Type: Article

References (39)

1. R.A. Star Treatment of acute renal failure Kidney Int. 54 1998 1817 1831
2. J.V. Bonventre, and J.M. Weinberg Recent advances in the pathophysiology of ischemic acute renal failure J. Am. Soc. Nephrol. 14 2003 2199 2210
3. M.A. Venkatachalam, K.A. Griffin, R. Lan, H. Geng, P. Saikumar, and A.K. Bidani Acute kidney injury: a springboard for progression in chronic kidney disease Am. J. Physiol. Renal Physiol. 298 2010 F1078 F1094
4. M.D. Okusa The inflammatory cascade in acute ischemic renal failure Nephron 90 2002 133 138
5. R. Bonegio, and W. Lieberthal Role of apoptosis in the pathogenesis of acute renal failure Curr. Opin. Nephrol. Hypertens. 11 2002 301 308
6. T.B. Drueke Which vitamin D derivative to prescribe for renal patients Curr. Opin. Nephrol. Hypertens. 14 2005 343 349
7. T. Weinreich, J. Merke, M. Schonermark, H. Reichel, M. Diebold, G.M. Hansch, and E. Ritz Actions of 1,25-dihydroxyvitamin D3 on human mesangial cells Am. J. Kidney Dis. 18 1991 359 366
8. T. Weinreich, A. Muller, R.P. Wuthrich, C. Booy, and U. Binswanger 1,25-dihydroxyvitamin D3 and the synthetic vitamin D analogue, KH, Modulate the growth of mouse proximal tubular cells 1060 Kidney Blood Press. Res. 19 1996 325 331
9. N. Xing, M.L. Maldonado, L.A. Bachman, D.J. McKean, R. Kumar, and M.D. Griffin Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways Biochem. Biophys. Res. Commun. 297 2002 645 652
10. J. Tian, Y. Liu, L.A. Williams, and D. de Zeeuw Potential role of active vitamin D in retarding the progression of chronic kidney disease Nephrol. Dial. Transplant. 22 2007 321 328
11. J.W. Park, E.H. Bae, I.J. Kim, S.K. Ma, C. Choi, J. Lee, and S.W. Kim Paricalcitol attenuates cyclosporine-induced kidney injury in rats Kidney Int. 77 2010 1076 1085
12. J.W. Park, E.H. Bae, I.J. Kim, S.K. Ma, C. Choi, J. Lee, and S.W. Kim Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats Am. J. Physiol. Renal Physiol. 298 2010 F301 F313
13. K. Makibayashi, M. Tatematsu, M. Hirata, N. Fukushima, K. Kusano, S. Ohashi, H. Abe, K. Kuze, A. Fukatsu, T. Kita, and T. Doi A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis Am. J. Pathol. 158 2001 1733 1741
14. M.D. Sanchez-Nino, M. Bozic, E. Cordoba-Lanus, P. Valcheva, O. Gracia, M. Ibarz, E. Fernandez, J.F. Navarro-Gonzalez, A. Ortiz, and J.M. Valdivielso Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy Am. J. Physiol. Renal Physiol. 302 2012 F647 F657
15. G. Xiang, T. Seki, M.D. Schuster, P. Witkowski, A.J. Boyle, F. See, T.P. Martens, A. Kocher, H. Sondermeijer, H. Krum, and S. Itescu Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia J. Biol. Chem. 280 2005 39394 39402
16. F. Ekici, B. Ozyurt, and H. Erdogan The combination of vitamin D3 and dehydroascorbic acid administration attenuates brain damage in focal ischemia Neurol. Sci. 30 2009 207 212
17. M.M. Yassin, D.W. Harkin, A.A. Barros D'Sa, M.I. Halliday, and B.J. Rowlands Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction World J. Surg. 26 2002 115 121
18. T. Miyaji, X. Hu, P.S. Yuen, Y. Muramatsu, S. Iyer, S.M. Hewitt, and R.A. Star Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice Kidney Int. 64 2003 1620 1631
19. L. Verstrepen, T. Bekaert, T.L. Chau, J. Tavernier, A. Chariot, and R. Beyaert TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme Cell. Mol. Life Sci. 65 2008 2964 2978
20. H. Wu, J. Ma, P. Wang, T.M. Corpuz, U. Panchapakesan, K.R. Wyburn, and S.J. Chadban HMGB1 contributes to kidney ischemia reperfusion injury J. Am. Soc. Nephrol. 21 2010 1878 1890
21. H. Wu, G. Chen, K.R. Wyburn, J. Yin, P. Bertolino, J.M. Eris, S.I. Alexander, A.F. Sharland, and S.J. Chadban TLR4 activation mediates kidney ischemia/reperfusion injury J. Clin. Invest. 117 2007 2847 2859
22. M.T. Lotze, and K.J. Tracey High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Nat. Rev. Immunol. 5 2005 331 342
23. R. Medzhitov, P. Preston-Hurlburt, and C.A. Janeway Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity Nature 388 1997 394 397
24. F. Chen, V. Castranova, and X. Shi New insights into the role of nuclear factor-kappaB in cell growth regulation Am. J. Pathol. 159 2001 387 397
25. J.I. Lee, and G.J. Burckart Nuclear factor kappa B: important transcription factor and therapeutic target J. Clin. Pharmacol. 38 1998 981 993
26. K. Sadeghi, B. Wessner, U. Laggner, M. Ploder, D. Tamandl, J. Friedl, U. Zugel, A. Steinmeyer, A. Pollak, E. Roth, G. Boltz-Nitulescu, and A. Spittler Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns Eur. J. Immunol. 36 2006 361 370
27. C. Thota, T. Farmer, R.E. Garfield, R. Menon, and A. Al-Hendy Vitamin D elicits anti-inflammatory response, inhibits contractile-associated proteins, and modulates Toll-like receptors in human myometrial cells Reprod. Sci. 20 2013 463 475
28. G. Murillo, V. Nagpal, N. Tiwari, R.V. Benya, and R.G. Mehta Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer J. Steroid Biochem. Biol. 121 2010 403 407
29. F. Li, P. Liu, X. Zhang, Q. Zhang, S. Tang, M. Zhu, and M. Qiu 1,25(OH)D-mediated amelioration of aortic injury in streptozotocin-induced diabetic rats Inflammation 36 2013 1334 1343
30. C.L. Roth, C.T. Elfers, D.P. Figlewicz, S.J. Melhorn, G.J. Morton, A. Hoofnagle, M.M. Yeh, J.E. Nelson, and K.V. Kowdley Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation Hepatology 55 2012 1103 1111
31. H.S. Hwang, K.J. Yang, K.C. Park, H.S. Choi, S.H. Kim, S.Y. Hong, B.H. Jeon, Y.K. Chang, C.W. Park, S.Y. Kim, S.J. Lee, and C.W. Yang Pretreatment with paricalcitol attenuates inflammation in ischemia-reperfusion injury via the up-regulation of cyclooxygenase-2 and prostaglandin E2 Nephrol. Dial. Transplant. 28 2013 1156 1166
32. P.V. Ranganathan, C. Jayakumar, R. Mohamed, Z. Dong, and G. Ramesh Netrin-1 regulates the inflammatory response of neutrophils and macrophages, and suppresses ischemic acute kidney injury by inhibiting COX-2-mediated PGE2 production Kidney Int. 83 2013 1087 1098
33. L.J. Crofford, B. Tan, C.J. McCarthy, and T. Hla Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes Arthritis Rheum. 40 1997 226 236
34. M.P. Charalambous, T. Lightfoot, V. Speirs, K. Horgan, and N.J. Gooderham Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue Br. J. Cancer 101 2009 106 115
35. K. Furuichi, T. Wada, H. Yokoyama, and K.I. Kobayashi Role of cytokines and chemokines in renal ischemia-reperfusion injury Drug News Perspect. 15 2002 477 482
36. J.C. Rice, J.S. Spence, D.L. Yetman, and R.L. Safirstein Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney Ren. Fail. 24 2002 703 723
37. M.L. Kielar, R. John, M. Bennett, J.A. Richardson, J.M. Shelton, L. Chen, D.R. Jeyarajah, X.J. Zhou, H. Zhou, B. Chiquett, G.T. Nagami, and C.Y. Lu Maladaptive role of IL-6 in ischemic acute renal failure J. Am. Soc. Nephrol. 16 2005 3315 3325
38. D.K. de Vries, J.H. Lindeman, D. Tsikas, E. de Heer, A. Roos, J.W. de Fijter, A.G. Baranski, J. van Pelt, and A.F. Schaapherder Early renal ischemia-reperfusion injury in humans is dominated by IL-6 release from the allograft Am. J. Transplant. 9 2009 1574 1584
39. X. Tan, X. Wen, and Y. Liu Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling J. Am. Soc. Nephrol. 19 2008 1741 1752